The Pharma Letter12h
Daiichi Sankyo appoints Hiroyuki Okuzawa as CEO
Japanese drugmaker Daiichi Sankyo has appointed Hiroyuki Okuzawa to succeed Sunao Manabe, as chief executive (CEO), effective April 1, 2025.
The Armenian Reporter16h
Great Diamond Partners LLC Lowers Position in AstraZeneca PLC (NASDAQ:AZN)
Great Diamond Partners LLC decreased its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 7.2% during the ...
The Armenian Reporter16h
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Mediolanum International Funds Ltd
Mediolanum International Funds Ltd decreased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 67.7% ...
Daily21h
Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu
Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY ...